---
figid: PMC3989546__nihms570312f1
figlink: /pmc/articles/PMC3989546/figure/F1/
number: F1
caption: 'In one scenario (right), IL-15 binds to its high affinity IL-15Rα expressed
  on an antigen-presenting cell and in turn is presented in trans to the IL-2/15Rβγ
  heterodimer. From there, effector cell activation can proceed via three distinct
  pathways: one involves JAK-STAT activation with the phosphorylated STAT proteins
  forming a heterodimer and trafficking to the nucleus for transcriptional activation;
  a second pathway involves the recruitment of Shc to a phosphorylated site on the
  IL-2/15Rβ chain followed by activation of Grb2. From there, Grb2 can proceed down
  a PI3K pathway to phosphorylate Akt, or can bind the guanine nucleotide exchange
  factor SOS to activate RAS-RAF and ultimately MAPK. Each contributes to effector
  cell survival and activation.In mast cells (left), IL-15 signals through a unique
  receptor chain, IL-15RX, to activate the JAK2/STAT5 pathway. IL-15 can also bind
  to the common γ chain to transmit its signals via Tyk2/STAT6 for initiation of a
  survival (Bcl-XL) and a Th2 immune response.Therapeutic interventions using anti-IL-15R
  antibody prevents binding and signaling of IL-15 through its receptor. Pharmacological
  inhibitors targeting the JAK/STAT pathway prevent activation and translocation of
  the STAT heterodimer to the nucleus. Finally, proteasomal inhibitors such as bortezomib
  prevent activation of NF-κB and Myc. Each of these therapies targets IL-15 signaling
  in malignant cells, but may have consequences for normal cells dependent upon IL-15.'
pmcid: PMC3989546
papertitle: 'Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer.'
reftext: Anjali Mishra, et al. Clin Cancer Res. ;20(8):2044-2050.
pmc_ranked_result_index: '27633'
pathway_score: 0.9331335
filename: nihms570312f1.jpg
figtitle: 'Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer'
year: ''
organisms:
- Homo sapiens
ndex: aaf00dc6-df09-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3989546__nihms570312f1.html
  '@type': Dataset
  description: 'In one scenario (right), IL-15 binds to its high affinity IL-15Rα
    expressed on an antigen-presenting cell and in turn is presented in trans to the
    IL-2/15Rβγ heterodimer. From there, effector cell activation can proceed via three
    distinct pathways: one involves JAK-STAT activation with the phosphorylated STAT
    proteins forming a heterodimer and trafficking to the nucleus for transcriptional
    activation; a second pathway involves the recruitment of Shc to a phosphorylated
    site on the IL-2/15Rβ chain followed by activation of Grb2. From there, Grb2 can
    proceed down a PI3K pathway to phosphorylate Akt, or can bind the guanine nucleotide
    exchange factor SOS to activate RAS-RAF and ultimately MAPK. Each contributes
    to effector cell survival and activation.In mast cells (left), IL-15 signals through
    a unique receptor chain, IL-15RX, to activate the JAK2/STAT5 pathway. IL-15 can
    also bind to the common γ chain to transmit its signals via Tyk2/STAT6 for initiation
    of a survival (Bcl-XL) and a Th2 immune response.Therapeutic interventions using
    anti-IL-15R antibody prevents binding and signaling of IL-15 through its receptor.
    Pharmacological inhibitors targeting the JAK/STAT pathway prevent activation and
    translocation of the STAT heterodimer to the nucleus. Finally, proteasomal inhibitors
    such as bortezomib prevent activation of NF-κB and Myc. Each of these therapies
    targets IL-15 signaling in malignant cells, but may have consequences for normal
    cells dependent upon IL-15.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JUN
  - IL15
  - GRB2
  - GAB2
  - CXCL8
  - IL4
  - BCL2L11
  - IL5
  - FOS
  - STAT6
  - BBC3
  - MAPK11
  - MYC
  - DNMT3B
  - BCL2L1
  - STAT5B
  - STAT1
  - AKT2
  - PIK3CA
  - JAK1
  - JAK2
  - JAK3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3CB
  - PIK3CD
  - PIK3R3
  - MAPK9
  - MAPK10
  - RAF1
  - ARAF
  - AKT3
  - AKT1
  - BCL2
  - KRAS
  - NRAS
  - STAT3
  - STAT4
  - STAT5A
  - PIK3CG
  - SHC3
  - SHC1
  - MAPK13
  - MCL1
  - BRAF
  - HRAS
  - MAPK14
  - MAPK3
  - MAPK8
  - TYK2
  - SHC4
  - SHC2
  - STAT2
  - TNF
  - SOS2
  - MAPK12
  - NFKB1
  - MAPK1
  - SOS1
  - Cancer
  - Noonan syndrome
genes:
- word: Bcl-2,c-myc,c-fos,c-jun,NF-KB,
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: IL-15
  symbol: IL-15
  source: hgnc_alias_symbol
  hgnc_symbol: IL15
  entrez: '3600'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Gab2
  symbol: GAB2
  source: hgnc_symbol
  hgnc_symbol: GAB2
  entrez: '9846'
- word: IL-8,
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL4,
  symbol: IL4
  source: hgnc_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: Bim,
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: IL-5
  symbol: IL-5
  source: hgnc_alias_symbol
  hgnc_symbol: IL5
  entrez: '3567'
- word: Bcl-2,c-myc,c-fos,c-jun,NF-KB,
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: Puma
  symbol: PUMA
  source: hgnc_alias_symbol
  hgnc_symbol: BBC3
  entrez: '27113'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: C-myc,
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Dnmt3b
  symbol: DNMT3B
  source: hgnc_symbol
  hgnc_symbol: DNMT3B
  entrez: '1789'
- word: Bcl-x
  symbol: Bcl-X
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Bcl-2,c-myc,c-fos,c-jun,NF-KB,
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Mcl-1,
  symbol: Mcl-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: JAK/STATinhibitors
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JAK/STATinhibitors
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: TNF-a,
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Tyk2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: JAK/STATinhibitors
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK/STATinhibitors
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3989546__F1
redirect_from: /figures/PMC3989546__F1
figtype: Figure
---
